Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 6 Nausea 6 Breast Neoplasms 3 Neoplasms 2 Hematologic Neoplasms 2 Weight Loss 1 Sedentary Behavior 1 Postoperative Nausea and Vomiting 1 Neoplasms, Plasma Cell 1 Muscular Atrophy 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma 1 Insulin Resistance 1 Hyperlipidemias 1 Hyperglycemia 1 Delirium 1 Child Nutrition Disorders 1 Cachexia 1 Anorexia 1 Advanced Cancer 1

Interventions

ostarine 3 rimabotulinumtoxinB 1 Standard of Care 1 Olanzapine 1 Enteral Nutrition 1 Cyproheptadine 1 Creatine 1 Botulinum Toxins, Type A 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Muscular Atrophy × Olanzapine × Clear all

NCT06175273 2025-09-18

POINT

University of Kentucky

Phase 2/3 Completed

Muscular Atrophy, Neoplasms, Child Nutrition Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡